|
|
Science Sparks @ ACTREC
|
2 October 2023 |
Vol. No. 12; Issue No. 598 |
|
Publications
|
1. Madkaiker D, Hiregoudar SS, Chavan P, Ojha S, Mendes J, Shastry S (2023). 'Ironing out the risk': Assessing the effect of plateletpheresis donation frequency on iron stores in South-Asian male donors. Vox Sanguinis.
2. Joshi S, Ramarajan L, Ramarajan N, Lee SS, Deshpande O, Fernandes E, Engineer M, Srivastava G, Vanmali V, Kannan S, Hawaldar R, Nair N, Parmar V, Thakkar P, Chitkara G, Gupta S, Badwe R (2023). Effectiveness of a decision aid plus standard care in surgical management among patients with early breast cancer: A randomized clinical Trial. JAMA Network Open. 6(10):e2335941
Thesis
1. Abhay Uthale. 2023. Deciphering the role of Mcl-1 in stress and autophagy in oral cancers. (LIFE09201504011) (Guide: Dr. Tanuja Teni)
2. Abhiram Girish Natu. 2023. Understanding the role of epigenetic alterations in acquirement of chemoresistance in cancer. (LIFE09201604020) (Guide: Dr. Sanjay Gupta)
|
|
|
Interesting Reads
|
Maas RR, Soukup K, Fournier N, Massara M, Galland S, Kornete M, Wischnewski V, Lourenco J, Croci D, Álvarez-Prado ÁF, Marie DN, Lilja J, Marcone R, Calvo GF, Santalla Mendez R, Aubel P, Bejarano L, Wirapati P, Ballesteros I, Hidalgo A, Hottinger AF, Brouland JP, Daniel RT, Hegi ME, Joyce JA( 2023). The local microenvironment drives activation of neutrophils in human brain tumors. Cell.
|
|
Video of the Week
|
|
Announcement of the 2023 Nobel Prize in Physiology |
|
|
|
|
|
|
Do You Know?
In 2016, FDA accelerated approval to palbociclib with fulvestrant(Faslodex) to treat advance breast cancer that worsend following intial hormone therapy.
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|